Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVX502 Influenza Vaccine in Older Adults
NCT00706732Phase 2Completed
- Sponsor
- AlphaVax, Inc.
- Start
- Jun 2008
- Primary completion
- Sep 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AVX502 in influenza, sponsored by AlphaVax, Inc.. Started Jun 2008; status: completed.
02
Drugs
AVX502
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00706732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706732.